Development of a novel humanized mouse model for improved evaluation of in vivo anti-cancer effects of anti-PD-1 antibody

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer in the clinic. Further discovery of novel drugs or therapeutic protocols that enhance efficacy requires reliable animal models that recapitulate human immune responses to ICI treatment in vivo. In this study, we utilized...

Descripción completa

Detalles Bibliográficos
Autores principales: Katano, Ikumi, Hanazawa, Asami, Otsuka, Iyo, Yamaguchi, Takuya, Mochizuki, Misa, Kawai, Kenji, Ito, Ryoji, Goto, Motohito, Kagawa, Takahiro, Takahashi, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548333/
https://www.ncbi.nlm.nih.gov/pubmed/34702924
http://dx.doi.org/10.1038/s41598-021-00641-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548333/
https://www.ncbi.nlm.nih.gov/pubmed/34702924
http://dx.doi.org/10.1038/s41598-021-00641-8

Ejemplares similares